What do systematic reviews say?

Single foetal haemoglobin inducer at any dose or duration vs another foetal haemoglobin inducer

• Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 84 participants
  Low

Single foetal haemoglobin inducer at any dose or duration vs placebo or usual care

• Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 35 participants
  Very low

Two or more foetal haemoglobin inducers at any dose or duration vs a usual management protocol, placebo or a single foetal haemoglobin inducer

The review found no eligible studies for this question.

• Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found